BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10435728)

  • 21. Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34+ cells.
    Krieger MS; Schiller G; Berenson JR; Stewart K; Noga SJ; Ballester O; Tarantolo S; Stiff P; Kuhn D; Scherzo E; Sing A; Jacobs C; White JM; DiPersio J
    Bone Marrow Transplant; 1999 Jul; 24(1):25-8. PubMed ID: 10435730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective.
    Bargetzi MJ; Passweg J; Baertschi E; Schoenenberger A; Gwerder C; Tichelli A; Burger J; Mingrone W; Herrmann R; Gratwohl A; Wernli M
    Bone Marrow Transplant; 2003 Jan; 31(2):99-103. PubMed ID: 12621490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
    Buckstein R; Imrie K; Spaner D; Potichnyj A; Robinson JB; Nanji S; Pennel N; Reis M; Pinkerton P; Dubé I; Hewitt K; Berinstein NL
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing platelet recovery after blood cell transplantation in multiple myeloma.
    Gertz MA; Lacy MQ; Inwards DJ; Pineda AA; Chen MG; Gastineau DA; Tefferi A; Kyle RA; Litzow MR
    Bone Marrow Transplant; 1997 Sep; 20(5):375-80. PubMed ID: 9339752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
    Sawada H; Wake A; Yamasaki Y; Izumi Y
    Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mobilization of autologous peripheral blood stem cells by combined chemotherapy and rhG-CSF].
    Shi H; Gu X; Zhu L
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):159-61. PubMed ID: 11783025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LDH elevation after autologous stem cell transplantation.
    Bolwell B; Pohlman B; Kalaycio M; Wise K; Goormastic M; Andresen S
    Bone Marrow Transplant; 1999 Jul; 24(1):53-5. PubMed ID: 10435735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
    Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma.
    Abonour R; Scott KM; Kunkel LA; Robertson MJ; Hromas R; Graves V; Lazaridis EN; Cripe L; Gharpure V; Traycoff CM; Mills B; Srour EF; Cornetta K
    Bone Marrow Transplant; 1998 Nov; 22(10):957-63. PubMed ID: 9849692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
    Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
    Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autografting Ph-negative blood precursor cells in chronic myeloid leukaemia.
    Frassoni F; Giordano D; Podestà M; Piaggio G; Benvenuto F; Pitto A; Figari O; Dejana A; Lerma E; Vassallo F; Sessarego M; Carella A
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S59-62. PubMed ID: 8769704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
    Boqué C; Grañena A
    Sangre (Barc); 1998 Apr; 43(2):155-63. PubMed ID: 9656777
    [No Abstract]   [Full Text] [Related]  

  • 33. Peripheral blood stem cell transplantation in myeloma using CD34 selected cells.
    Johnson RJ; Owen RG; Smith GM; Child JA; Galvin M; Newton LJ; Rawstron A; Major K; Woodhead V; Robinson F; Jack A; Morgan GJ
    Bone Marrow Transplant; 1996 May; 17(5):723-7. PubMed ID: 8733688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulocyte colony-stimulating factor given in addition to interferon-alpha to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemia.
    Archimbaud E; Michallet M; Philip I; Charrin C; Clapisson G; Belhabri A; Guilhot F; Stryckmans P; Adeleine P; Fière D
    Br J Haematol; 1997 Dec; 99(3):678-84. PubMed ID: 9401084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia.
    Boqué C; Petit J; Sarrá J; Cancelas JA; Muñoz J; Español JI; de la Banda E; Aventin A; Berlanga J; Ferrá C; Amill B; Torrico C; Azqueta C; Llucià M; García J; Grañena A
    Bone Marrow Transplant; 1996 Nov; 18(5):879-84. PubMed ID: 8932840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients.
    Gandhi MK; Jestice K; Scott MA; Bloxham D; Bass G; Marcus RE
    Bone Marrow Transplant; 1999 Jan; 23(1):9-13. PubMed ID: 10037044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF.
    Pratt G; Johnson RJ; Rawstron AC; Barnard DL; Morgan GJ; Smith GM
    Bone Marrow Transplant; 1998 Mar; 21(5):455-60. PubMed ID: 9535037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure.
    Tosi P; Zamagni E; Ronconi S; Benni M; Motta MR; Rizzi S; Tura S; Cavo M
    Leukemia; 2000 Jul; 14(7):1310-3. PubMed ID: 10914557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful mobilization of peripheral blood stem cells in heavily pretreated myeloma patients with G-CSF alone.
    Kröger N; Zeller W; Hassan HT; Krüger W; Renges H; Hummel K; Gutensohn K; Lölliger C; Zander AR
    Ann Hematol; 1998 Jun; 76(6):257-62. PubMed ID: 9692813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mobilization of Philadelphia-negative peripheral blood progenitor cells with chemotherapy and rhuG-CSF in chronic myelogenous leukaemia patients with a poor response to interferon-alpha.
    Carella AM; Simonsson B; Link H; Lennard A; Boogaerts M; Gorin NC; Tomas-Martinez JF; Dabouz-Harrouche F; Gautier L; Badri N
    Br J Haematol; 1998 Apr; 101(1):111-8. PubMed ID: 9576191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.